Cabot Corporation (CBT) Stock Falls on Q1 2026 Earnings

Cabot Corporation (CBT) reported first-quarter 2026 revenue of $849.0 million, down 11.1% year-over-year and below the consensus revenue estimate of $896.0 million.

Revenue: $849.0 million (down 11.1% year-over-year)

Cost of sales: $638.0 million (down 11.4% year-over-year)

Gross profit: $211.0 million (down 10.2% year-over-year)

Operating profit: $129.0 million (down 16.8% year-over-year)

Net income attributable to common shareholders: $73.0 million (down 21.5% year-over-year)

Diluted earnings per share came in at 1.37, a decrease of 18.0% year-over-year and slightly below the EPS estimate of 1.4223.

Cash from operating activities: $126.0 million (up 1.6% year-over-year)

Capital expenditures (purchases of property, plant and equipment): $69.0 million (down 10.4% year-over-year)

Cash and cash equivalents: $230.0 million (up 25.7% year-over-year)

Total liabilities: $2.16 billion (up 1.7% year-over-year)

The company missed expectations on both top and bottom lines, with revenue roughly short by about $47.0 million (approximately 5.3%) and EPS about 3.7% below the estimate; shares were down about 1.11% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Cabot Corporation Insider Trading Activity

Cabot Corporation insiders have traded $CBT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CBT stock by insiders over the last 6 months:

SEAN D KEOHANE (President and CEO) has made 0 purchases and 4 sales selling 114,436 shares for an estimated $9,072,094.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Cabot Corporation Hedge Fund Activity

We have seen 161 institutional investors add shares of Cabot Corporation stock to their portfolio, and 221 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

COPELAND CAPITAL MANAGEMENT, LLC removed 524,278 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $34,749,145
LIGHTROCK NETHERLANDS B.V. added 317,934 shares (+227.3%) to their portfolio in Q4 2025, for an estimated $21,072,665
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 204,975 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $15,588,348
AMERICAN CENTURY COMPANIES INC added 140,665 shares (+8.4%) to their portfolio in Q3 2025, for an estimated $10,697,573
QUBE RESEARCH & TECHNOLOGIES LTD removed 126,370 shares (-42.3%) from their portfolio in Q3 2025, for an estimated $9,610,438
VICTORY CAPITAL MANAGEMENT INC added 102,764 shares (+259.2%) to their portfolio in Q3 2025, for an estimated $7,815,202
BARCLAYS PLC added 101,168 shares (+60.6%) to their portfolio in Q3 2025, for an estimated $7,693,826

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Cabot Corporation Analyst Ratings

Wall Street analysts have issued reports on $CBT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Underweight" rating on 11/28/2025
Mizuho issued a "Outperform" rating on 11/17/2025

To track analyst ratings and price targets for Cabot Corporation, check out Quiver Quantitative's $CBT forecast page.

Cabot Corporation Price Targets

Multiple analysts have issued price targets for $CBT recently. We have seen 3 analysts offer price targets for $CBT in the last 6 months, with a median target of $74.0.

Here are some recent targets:

Joshua Spector from UBS set a target price of $74.0 on 01/12/2026
John Roberts from Mizuho set a target price of $80.0 on 12/18/2025
Jeffrey Zekauskas from JP Morgan set a target price of $54.0 on 11/28/2025